Neuralgic amyotrophy

G6_NEURAMYO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G54.5 Hospital discharge: ICD-9 — 3535 Cause of death: ICD-10 — G54.5 Cause of death: ICD-9 — 3535 2 out of 7 registries used, show all original rules.	65
4. Check minimum number of events None	65
5. Include endpoints None	65
6. Filter based on genotype QC (FinnGen only)	65

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G54
Name in latin: Amyotrophia neuralgica

NAME	G6_NEURAMYO
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G545
HD_ICD_9	3535
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G545
COD_ICD_9	3535
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Neuralgic amyotrophy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	398	163	231
Only index persons	371	152	219
Unadjusted period prevalence (%)
Whole population	0.01	0.00	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	52.03	50.89	52.84
Only index persons	51.07	50.12	51.73

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	65	25	40
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	60.58	58.50	61.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
60: Matched controls
599

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G54.5

ICD-10 Finland

Neuralgic amyotrophy

+∞

83.3

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

16.1

8.9

TAB00

NOMESCO Finland

Lumbar puncture

18.0

8.7

R4120

NOMESCO Finland

Occupational therapy

12.4

7.5

N03AX16

ATC

pregabalin; oral

5.0

6.8

G56.0

ICD-10 Finland

Carpal tunnel syndrome

30.2

6.4

G54.9

ICD-10 Finland

Nerve root and plexus disorder, unspecified

+∞

6.4

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

12.79

4.93

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

8.93

4.19

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

8.10

3.99

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

6.84

3.62

1.3

1.1

—

(42870588) Differential panel, method unspecified - Blood

175

2.63

3.56

4.8

5.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

5.62

3.51

1.3

1.2

343.4

198.6

e6/l

—

(3006315) Basophils [#/volume] in Blood

265

2.65

3.45

6.2

5.9

0.0

e9/l

0.74

230

(3016018) Differential panel - Cerebral spinal fluid

9.28

3.33

1.3

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

9.28

3.33

1.0

—

(3023410) Appearance of Cerebral spinal fluid

9.28

3.33

1.3

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

270

2.57

3.24

6.4

5.9

2.7

2.0

e9/l

0.39

241

(3001604) Monocytes [#/volume] in Blood

263

2.51

3.15

6.4

5.8

0.6

e9/l

0.24

229

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

198

2.35

2.86

1.8

2.0

96.8

88.0

pmol/l

0.41

105

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

5.09

2.67

1.0

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.54

2.66

1.3

22.8

24.0

iu/ml

—

(3023368) Bacteria identified in Blood by Culture

146

2.30

2.57

5.7

4.8

—

(4027681)

6.65

2.41

1.2

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

238

2.15

2.34

3.1

4.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

4.96

2.33

1.5

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

377

2.22

2.02

3.9

4.0

12.9

11.6

mm/h

0.18

345

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

4.82

1.98

1.2

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

4.82

1.98

1.2

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

4.41

1.86

1.4

1.2

0.2

0.3

g/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

4.07

1.75

1.4

1.2

1.1

1.3

g/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2.24

1.69

1.1

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

172

1.85

1.53

3.0

2.4

—

(3000850) Epithelial cells [#/volume] in Urine

113

1.96

1.53

3.4

2.5

3.4

3.3

e6/l

0.03

104

(3032080) INR in Blood by Coagulation assay

220

1.78

1.44

5.2

8.9

1.2

1.3

inr

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.19

1.44

1.8

1.7

—

(3021589) Normoblasts [#/volume] in Blood

231

1.76

1.39

9.8

9.4

0.0

e9/l

0.62

188

(3005719) IgG [Mass/volume] in Serum or Plasma

2.21

1.33

5.3

2.9

8.1

10.1

g/l

—

(40758558) Short blood count panel - Blood

146

1.77

1.25

9.9

6.3

—

(3045414) Leukocytes [Presence] in Urine

2.76

1.24

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.76

1.24

1.2

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.76

1.24

1.0

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.04

1.23

1.9

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.20

1.20

1.7

1.6

—

(3044889) 12 lead EKG panel

388

1.76

1.20

4.0

3.8

—

(1761868) Lipid panel - Serum or Plasma

206

0.54

1.15

2.1

2.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.97

1.14

1.2

1.3

—

(3019060) Gas panel - Arterial blood

2.08

1.13

2.3

16.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.33

1.12

3.0

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.37

1.05

7.0

3.0

2.9

3.9

g/l

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.37

1.05

7.0

3.0

7.0

7.4

g/l

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.37

1.05

7.0

3.0

—

(3022145) Colonoscopy Study observation

1.93

1.02

1.2

1.3

—

(40768797) Stomach Pathology biopsy report

1.88

1.01

1.3

—

(36304419) Bacteria [Presence] in Urine

164

1.62

0.99

4.9

2.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

539

2.02

0.94

23.1

14.8

25.9

23.9

mg/l

0.14

423

(3012516) Albumin [Mass/volume] in Urine

141

1.60

0.89

1.9

3.2

142.2

60.5

mg/l

0.29

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

133

1.61

0.86

2.4

2.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

207

1.52

0.83

4.1

2.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

509

1.72

0.82

20.9

13.5

84.4

81.1

ml/min/173m2

0.55

415

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.81

0.0

1.6

—

(1002224) Polysomnography panel

0.00

0.81

0.0

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1.68

0.79

2.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

101

1.63

0.79

4.3

2.1

2.2

0.9

e6/l

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

110

1.60

0.78

1.8

2.0

0.6

1.1

mg/l

1.00

(3004588) Protein electrophoresis panel - Serum or Plasma

1.89

0.75

8.7

2.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

211

1.48

0.75

3.8

18.3

43.0

ng/l

0.96

150

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.62

0.74

2.1

2.0

—

(3022313) Gas panel - Capillary blood

2.08

0.74

4.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.60

0.71

4.1

2.4

1.6

e6/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

131

1.52

0.69

2.8

3.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

159

1.47

0.67

2.2

3.8

19.7

7.1

mg/mmol

0.32

106

(3022621) pH of Urine by Test strip

1.78

0.65

1.4

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

2.8

—

(3009343) pH of Capillary blood

1.73

0.58

4.0

3.9

—

7.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

495

1.54

0.57

23.6

16.1

40.5

40.7

0.09

379

(3007853) Bacteria identified in Skin by Aerobe culture

1.47

0.54

3.1

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

331

1.36

0.52

2.7

3.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

112

1.44

0.50

3.1

5.0

—

(3023520) Reticulocytes [#/volume] in Blood

1.55

0.49

2.9

4.0

68.4

75.9

e9/l

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.55

0.49

8.9

3.0

65.7

66.5

g/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

364

1.34

0.48

3.5

4.3

—

(40768804) Tissue Pathology biopsy report

227

1.32

0.45

1.8

2.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

266

1.32

0.45

3.2

4.5

0.0

estimate

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.61

0.43

5.8

27.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1.41

0.43

3.0

3.9

1.8

2.0

—

(40768793) Breast Pathology biopsy report

0.00

0.42

0.0

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.41

0.0

4.2

—

(36660697) Celiac disease serology panel - Serum

1.46

0.40

1.2

—

(3013512) EKG study

164

1.32

0.39

3.9

4.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.51

0.37

1.3

1.8

—

(40761536) Microorganisms panel - Urine sediment

1.47

0.37

2.0

4.0

—

(4010399)

1.43

0.36

1.3

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

272

1.27

0.36

2.5

3.5

0.0

estimate

—

(3022948) Iron [Moles/volume] in Serum or Plasma

0.67

0.36

2.2

10.7

14.3

umol/l

—

(3000991) Gas panel - Venous blood

1.33

0.34

5.8

9.5

—

(3019225) pH of Specimen

1.33

0.34

4.0

4.4

—

(3000492) Spirometry study

1.42

0.33

1.3

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

149

1.29

0.32

3.5

2.8

0.5

0.7

ug/l

0.80

104

(3041096) Erythrocytes [Presence] in Urine by Automated

140

0.74

0.32

2.0

3.1

—

(3015736) pH of Urine

197

1.26

0.32

2.6

3.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.68

0.28

11.4

8.8

—

(3026008) Bacteria identified in Urine by Culture

144

1.24

0.25

4.2

2.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.31

0.23

1.2

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.24

0.22

2.4

2.8

3.8

4.7

kpa

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

3.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.21

0.0

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.21

0.0

1.6

—

5.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.21

0.0

3.6

—

17.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.21

0.0

1.6

—

(40761535) Cells panel - Urine sediment

1.27

0.21

4.5

3.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.22

0.20

3.0

3.9

5.9

5.7

kpa

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.20

0.0

3.1

—

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.20

0.0

3.9

—

66.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.20

0.0

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.20

0.0

3.1

—

7.0

—

(3002256) Pathology report gross observation

1.26

0.19

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.20

0.17

2.0

1.9

1.8

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

0.78

0.16

2.0

2.3

21.8

23.7

—

(3003694) ABO and Rh group [Type] in Blood

131

1.19

0.16

1.2

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

201

1.14

0.14

4.0

4.3

24.3

20.6

—

101

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.18

0.10

1.0

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

144

0.88

0.09

3.5

4.0

0.0

estimate

—

(3012544) pH of Venous blood

1.12

0.09

3.0

4.4

—

(3019150) Specific gravity of Urine by Refractometry

113

0.86

0.09

4.2

4.0

—

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

456

1.11

0.08

27.9

17.9

13.6

14.1

1.53

448

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

204

0.90

0.08

3.1

3.6

—

(3000494) Fungus identified in Specimen by Culture

1.06

0.08

1.1

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.0

4.8

—

24.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

268.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.88

0.00

1.2

1.7

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

3.4

—

106.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

24.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

0.92

0.00

6.5

1.7

174.2

151.2

ug/g

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

3.4

—

3.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.90

0.00

1.4

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

3.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3004451) EKG impression Narrative

0.00

0.0

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.02

0.00

1.2

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.00

0.00

1.3

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

0.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.9

—

48.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

0.0

3.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.0

3.0

—

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.02

0.00

1.2

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

2.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

4.0

—

(3011985) Renin [Units/volume] in Plasma

0.00

0.0

1.1

—

17.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.7

—

35.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

12.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

1.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEURAMYO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_NEURAMYO.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: G6_NEURAMYO – Neuralgic amyotrophy

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Neuralgic amyotrophy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints